Skip to main content

Table 4. Treatment of relapse after haplo-SCT

From: Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT

  1. ALL acute lymphoblastic leukemia, AML acute myeloid leukemia, SCT stem cell transplant, TKI tyrosine kinase inhibitors, DLI donor lymphocyte infusion